Wei-Ting Liu
Impact in
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Ubiquitin and proteasome pathways 2
- Metabolism, Diabetes, and Cancer 2
- Gut microbiota and health 2
-
- Quinazolinone synthesis and applications 2
- Co-authors
- Pieter C. Dorrestein (7 shared papers)Clifton E. Barry (2 shared papers)Kristin E. Burns (2 shared papers)Helena I. Boshoff (1 shared paper)Pavel A. Pevzner (3 shared papers)Julio Ng (2 shared papers)Jane Y. Yang (2 shared papers)Kejun Hou (7 shared papers)
- Journals
- Disease Markers (1 paper)Molecular BioSystems (1 paper)PLoS ONE (1 paper)Frontiers in Microbiology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Wei-Ting Liu
28 papers receiving 863 citations
Peers
Comparison fields: 5 of 119
- Pharmacology 126
- Structural Biology 11
- Molecular Biology 513
- Biotechnology 60
- Biological Psychiatry 10
Countries citing papers authored by Wei-Ting Liu
This map shows the geographic impact of Wei-Ting Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Ting Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Ting Liu more than expected).
Fields of papers citing papers by Wei-Ting Liu
This network shows the impact of papers produced by Wei-Ting Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Ting Liu. The network helps show where Wei-Ting Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei-Ting Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 159 | |
| 2 | 2008 | 122 | |
| 3 | 2011 | 102 | |
| 4 | 2009 | 74 | |
| 5 | 2009 | 73 | |
| 6 | 2022 | 62 | |
| 7 | 2022 | 48 | |
| 8 | 2013 | 43 | |
| 9 | 2022 | 31 | |
| 10 | 2011 | 30 | |
| 11 | 2017 | 28 | |
| 12 | 2014 | 22 | |
| 13 | 2007 | 21 | |
| 14 | 2021 | 11 | |
| 15 | 2022 | 8 | |
| 16 | 2025 | 8 | |
| 17 | Aggravated DNA damage as a basis for enhanced glioma cell killing by MJ-66 in combination with minocycline. | 2014 | 6 |
| 18 | 2024 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2021 | 3 |
About Wei-Ting Liu
Wei-Ting Liu is a scholar working on Molecular Biology, Organic Chemistry, Pathology and Forensic Medicine, Oncology and Endocrinology, Diabetes and Metabolism, having authored 30 papers that have together received 873 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Gut microbiota and health (2 papers), Peptidase Inhibition and Analysis (2 papers), Stress Responses and Cortisol (2 papers), Quinazolinone synthesis and applications (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Pharmacology (126 citations), Structural Biology (11 citations), Molecular Biology (513 citations), Biotechnology (60 citations) and Biological Psychiatry (10 citations). Wei-Ting Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Pieter C. Dorrestein, Clifton E. Barry, Kristin E. Burns, Helena I. Boshoff, Pavel A. Pevzner, Julio Ng, Jane Y. Yang, Kejun Hou, Zezhen Wu and Paul D. Straight. Their work appears in journals such as Disease Markers, Molecular BioSystems, PLoS ONE, Frontiers in Microbiology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.